244 related articles for article (PubMed ID: 23089713)
1. Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis.
Kolasa-Trela R; Fil K; Bazanek M; Grudzień G; Sobczyk D; Sadowski J; Undas A
Clin Chem Lab Med; 2012 Oct; 50(10):1825-31. PubMed ID: 23089713
[TBL] [Abstract][Full Text] [Related]
2. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans.
Perrot N; Thériault S; Rigade S; Chen HY; Dina C; Martinsson A; Boekholdt SM; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Engert JC; Wareham NJ; Clavel MA; Pibarot P; Smith JG; Schott JJ; Mathieu P; Bossé Y; Thanassoulis G; Arsenault BJ
Heart; 2020 Sep; 106(18):1407-1412. PubMed ID: 32636298
[TBL] [Abstract][Full Text] [Related]
4. Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study.
Capoulade R; Mahmut A; Tastet L; Arsenault M; Bédard É; Dumesnil JG; Després JP; Larose É; Arsenault BJ; Bossé Y; Mathieu P; Pibarot P
JACC Cardiovasc Imaging; 2015 Jan; 8(1):26-33. PubMed ID: 25499129
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
[TBL] [Abstract][Full Text] [Related]
6. Circulating Lp-PLA2 is associated with high valvuloarterial impedance and low arterial compliance in patients with aortic valve bioprostheses.
Mahmut A; Mahjoub H; Boulanger MC; Dahou A; Bouchareb R; Capoulade R; Arsenault BJ; Larose E; Bossé Y; Pibarot P; Mathieu P
Clin Chim Acta; 2016 Apr; 455():20-5. PubMed ID: 26797670
[TBL] [Abstract][Full Text] [Related]
7. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.
Ragab SM; Safan MA; Obeid OM; Sherief AS
Hematology; 2015 May; 20(4):228-38. PubMed ID: 25056687
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Lipoprotein-associated Phospholipase A2 in Serum in Patients With Stage 3-5 Chronic Kidney Disease.
Wang Y; Li SS; Na SP; Yu CY; Ji Y; Zhao SL; Xie RJ; Bao YS
Am J Med Sci; 2016 Oct; 352(4):348-353. PubMed ID: 27776715
[TBL] [Abstract][Full Text] [Related]
10. Lp-PLA2 is associated with structural valve degeneration of bioprostheses.
Mahmut A; Mahjoub H; Boulanger MC; Fournier D; Després JP; Pibarot P; Mathieu P
Eur J Clin Invest; 2014 Feb; 44(2):136-45. PubMed ID: 24328921
[TBL] [Abstract][Full Text] [Related]
11. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.
Lavi S; McConnell JP; Rihal CS; Prasad A; Mathew V; Lerman LO; Lerman A
Circulation; 2007 May; 115(21):2715-21. PubMed ID: 17502572
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of lipoprotein-associated phosholipase A2 and plaque burden/composition in young adults.
Celik O; Ozturk D; Akin F; Satilmis S; Yalcin AA; Erturk M; Ayca B; Akturk F; Birand A; Pusuroglu H; Kaya MG
Coron Artery Dis; 2015 May; 26(3):266-71. PubMed ID: 25647459
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
[TBL] [Abstract][Full Text] [Related]
14. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
15. Differential Expression of Lipoprotein-Associated Phospholipase A2 in Monocyte Subsets: Impact of Uremia and Atherosclerosis.
Ulrich C; Trojanowicz B; Fiedler R; Kohler F; Wolf AF; Seibert E; Girndt M
Nephron; 2017; 135(3):231-241. PubMed ID: 27992874
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
[TBL] [Abstract][Full Text] [Related]
17. Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children.
Sakka S; Siahanidou T; Voyatzis C; Pervanidou P; Kaminioti C; Lazopoulou N; Kanaka-Gantenbein C; Chrousos GP; Papassotiriou I
Clin Chem Lab Med; 2015 Jun; 53(7):1119-25. PubMed ID: 25581763
[TBL] [Abstract][Full Text] [Related]
18. Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography.
Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Thuboi S; Ogita M; Miyazaki T; Nishino A; Yokoyama K; Kurata T; Yatomi Y; Daida H
Ann Clin Biochem; 2012 Nov; 49(Pt 6):527-33. PubMed ID: 22933444
[TBL] [Abstract][Full Text] [Related]
19. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
Cai A; Li G; Chen J; Li X; Li L; Zhou Y
BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipoprotein-associated phospholipase A2 mass is elevated in STEMI compared to non-STEMI patients but does not discriminate between myocardial infarction and non-cardiac chest pain.
Dullaart RP; van Pelt LJ; Kwakernaak AJ; Dikkeschei BD; van der Horst IC; Tio RA
Clin Chim Acta; 2013 Sep; 424():136-40. PubMed ID: 23756128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
